When the dominant electronic health record vendor decides to build its own clinical AI, the entire digital health startup ecosystem faces an existential threat.

Epic commands a massive 43.7% share of the acute-care hospital market. Now, it is aggressively building native AI tools for clinicians and patients. This move directly threatens the venture-backed startups that previously filled these gaps.

For years, health systems relied on third-party software for specialized tasks. But over 70% of health system leaders now prefer an “Epic-first” approach to new technology. Why buy a niche tool when your primary software vendor offers it built-in?

The Startup Squeeze

This shift puts intense pressure on companies like Abridge, Doximity, and OpenEvidence. Epic once partnered with some of these players. Now, it is competing with them directly.

Startups must now prove they can deliver vastly superior return on investment to survive. Hospitals are still open to third-party tools, but the bar for entry is suddenly much higher.

Cracks in the Fortress

Yet, Epic’s dominance is not guaranteed. The company faces a reported FTC antitrust investigation into its employment agreements and data-sharing practices. Key executives are also departing.

Meanwhile, legacy rivals like Oracle Health are mounting their own AI offensives. Epic’s land grab could trigger regulatory pushback just as its competition intensifies.

This is a classic platform play. Epic wants to be both the operating system and the application layer. Startups must pivot from being simple features to becoming indispensable platforms of their own.